What is Caerus?
Caerus operates as a sophisticated medical technology firm, specializing in the engineering and manufacturing of advanced pain relief solutions and orthopedic bracing systems. With a diversified portfolio that spans four distinct business units, the company addresses critical patient needs across both human and veterinary medicine. Operating out of an ISO 13485 certified and FDA-registered facility in Blaine, Minnesota, Caerus maintains rigorous quality control standards. Its flagship brands, including OrthoCor Medical and Animal Ortho Care, exemplify the firm's commitment to patient-centered innovation and high-performance medical hardware. By integrating clinical efficacy with manufacturing precision, Caerus has established itself as a reliable partner in the healthcare supply chain, focusing on scalable orthopedic support technologies that improve mobility and quality of life.
How much funding has Caerus raised?
Caerus has raised a total of $2.9M across 2 funding rounds:
Private Equity
$2.5M
Debt
$350K
Private Equity (2016): $2.5M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Key Investors in Caerus
PPP
Public-Private Partnership
Undisclosed Investor
An institutional backer focused on long-term value creation and strategic development within the medical technology and healthcare manufacturing sectors.
Undisclosed Investor
A strategic partner providing the necessary liquidity to support large-scale medical device innovation and facility expansion.
What's next for Caerus?
With the recent capital deployment, Caerus is positioned to accelerate its research and development initiatives, likely focusing on the expansion of its proprietary bracing technologies and the scaling of its manufacturing capabilities. The strategic focus will likely shift toward deepening market penetration in the veterinary orthopedic space while simultaneously optimizing its human-centric medical device offerings. As the company navigates this growth phase, the emphasis will remain on maintaining regulatory excellence and operational efficiency. Investors and industry stakeholders will be monitoring how Caerus utilizes this financing to capture additional market share and drive long-term value in the competitive medical technology ecosystem, particularly as it seeks to integrate more advanced materials and patient-monitoring features into its existing product lines.
See full Caerus company page
